DOCSLIB.ORG

Paclitaxel, Carboplatin and 1,25-D3 Inhibit Proliferation of Endometrial

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Paclitaxel, Carboplatin and 1,25-D3 Inhibit Proliferation of Endometrial ANTICANCER RESEARCH 37 : 6575-6581 (2017) doi:10.21873/anticanres.12114 Paclitaxel, Carboplatin and 1,25-D3 Inhibit Proliferation of Endometrial Cancer Cells In Vitro TEA KUITTINEN 1, PÄIVI ROVIO 1, SYNNÖVE STAFF 1,2 , TIINA LUUKKAALA 3,4 , ANNE KALLIONIEMI 5,6 , SEIJA GRÉNMAN 7,8 , MARITA LAURILA 9 and JOHANNA MÄENPÄÄ 1,10 1Department of Obstetrics and Gynaecology, Tampere University Hospital, Tampere, Finland; 2Laboratory of Cancer Biology, BioMediTech Institute, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland; 3Research and Innovation Centre, Tampere University Hospital, Tampere, Finland; 4Health Sciences, Faculty of Social Sciences, University of Tampere, Tampere, Finland; 5BioMediTech Institute and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland; 6Fimlab Ltd, Tampere University Hospital, Tampere, Finland; 7Department of Obstetrics and Gynaecology, Turku University Hospital, Turku, Finland; 8University of Turku, Turku, Finland; 9Department of Pathology, Fimlab Ltd, Tampere University Hospital, Tampere, Finland; 10 Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland Abstract. Background/Aim: Endometrial cancer cells are combination of these compounds. The corresponding numbers known to be sensitive to carboplatin and paclitaxel. in UT-EC-3 were 70%, 33% and 65%, respectively. 1,25-D3 Further more , vitamin D (1,25-D3) has been reported to inhibit suppressed cell growth 88% with paclitaxel, 63% with endometrial cancer cell growth both as a single agent and carboplatin and 87% with their combination in the UT-EC-1 combined with carboplatin. However, there are no studies cell line. Conclusion: In both cell lines, single-agent paclitaxel comparing the effect of paclitaxel and carboplatin as single was as effective as the combination of the compounds and agents vs. in combination in endometrial cancer cell lines. more effective than single carboplatin. 1,25-D3 may further Neither has the effect of 1,25-D3 been studied with paclitaxel. contribute to the cytotoxic effect of these agents. The present study investigated the effect of paclitaxel, carboplatin and 1,25-D3 on the growth of endometrial cancer Endometrial cancer is the most common gynecological cells in vitro. Materials and Methods: Two endometrial malignancy in developed countries. In Finland incidence is adenocarcinoma cell lines (UT-EC-1 and UT-EC-3) were 13.9 per 100,000 persons a year (1). Most women are cultured with different doses of paclitaxel, carboplatin and diagnosed with early-stage disease and have a high cure rate 1,25-D3. The cellular VDR (vitamin D receptor) mRNA levels with surgery alone with a reported 5-year survival rate of were measured and the expression of estrogen (ER) and 90% (2). Still up to 25% of women will have advanced, high progesterone (PR) receptors by the cells was determined. grade or recurrent disease and require additional treatment. Results: In the UT-EC-1 cell line the growth inhibition was In these cases, the therapeutic response to cytotoxic and 72% with paclitaxel, 54% with carboplatin and 73% with the hormonal agents has been typically only partial and of short duration. There is no generally accepted standard chemotherapy in treatment of advanced and recurrent endometrial carcinoma but simultaneous administration of This Αrticle is freely accessible online. carboplatin and paclitaxel or carboplatin and pegylated liposomal doxorubicin are widely used (3-8). Correspondence to: Tea Kuittinen, Department of Obstetrics and Vitamin D is an antiproliferative and immunomodulatory Gynaecology, Tampere University Hospital, Teiskontie 35, 33520 secosteroid hormone with a well-established role in Tampere, Finland. Tel: +3585031169810, e-mail: tea.kuittinen@ xfimnet.fi maintenance of calcium synthesis. Active metabolite of vitamin D, 1alpha,25-dihydroxyvitamin D 3 (1,25-D3) binds Key Words: Vitamin D, 1,25-D3, endometrial cancer in vitro , to the vitamin D receptor (VDR) in the cell nucleus. The paclitaxel, carboplatin, growth inhibition, VDR. function and/or expression of the VDR is needed for the 6575 ANTICANCER RESEARCH 37 : 6575-6581 (2017) growth regulatory effects of 1,25-D3 in vitro and disabled used were 1-100 nM and fresh stock solutions were made for each VDR activity leads to 1,25-D3 insensitivity and accelerated experiment. Carboplatin was diluted in sterile water to get a solution tumorigenesis (9). Many different cell types, including of 100 μg/ml. The final dilutions used were 0.1-20 μg/ml. The dilutions were made immediately before use. 1,25-D3 was diluted in normal and malignant endometrial cells, contain VDR and DMEM to get final 0.1-100 nM solutions. The concentrations of 1alpha hydroxylases to synthesize active 1,25-D3 locally (10, drugs were based on previous reports as well as physiological 11). This active metabolite does not enter the circulation and relevance (23, 24, 27, 28). has no effect on calcium homeostasis, but is rather degraded by 24-hydroxylases. VDR, ER and PR expression analyses. The VDR mRNA levels in UT- 1,25-D3 is well known for its antiproliferative roles EC-1 and UT-EC-3 cells were measured by qRT–PCR using the LightCycler equipment (Roche, Mannheim, Germany). Total RNA including the induction of G 0-G 1 cell-cycle arrest with was extracted using the RNeasy Mini Kit (Qiagen, Valencia, CA, associated down-regulation of oncogenic cyclins D1 and D3 USA) and was reverse transcribed with SuperScript™ First-Strand and p27/p21 induction (12-15). 1,25-D3 is responsible for Synthesis System for RT–PCR (Invitrogen, Carlsbad, CA, USA) as VDR-mediated apoptosis and inhibits angiogenesis and described (29). qRT-PCR was performed using 20 μM gene specific differentiation in a variety of cancer types (13, 16-20). 1,25- primers (Sigma-Aldrich, sense 5’ ATCGGCATGATGAAGGAGTT D3 is a potential antitumor agent because of its ability to 3’, antisense 5’ TGCTCCTCAGACAGCTTGG 3’) and 10 μM UPL regulate cancer cell growth. 1,25-D3 has been found to probe (probe number # 12). The PCR program included the following inhibit endometrial cancer cell growth both as a single agent steps: 10 min denaturation at 95˚C followed by 45 cycles of 10 s denaturation at 95˚C, 30 s annealing at 60˚C and 1 s elongation at (21) and combined with carboplatin (22). 72˚C. The expression levels were normalized using glyceraldehyde- Endometrial cancer cells are sensitive to carboplatin, 3-phosphate dehydrogenase (GAPD) housekeeping gene. cisplatin and paclitaxel (23, 24). Still there are no studies The expression of estrogen (ER) and progesterone (PR) receptors comparing paclitaxel and carboplatin as single agents vs. in in both cell lines was determined with immunohistochemical combination in endometrial cancer in vitro or in vivo . In staining. ER and PR immunostainings were performed using addition, there are no studies examining the effect of vitamin Ventana Benchmark Ultra automated IHC/ISH Slide staining system D with paclitaxel or the combination of paclitaxel and (Ventana Medical Systems, AZ, USA). Deparaffinization and antigen retrieval were performed using Roche Ventana reagents (EZ carboplatin on endometrial cancer cells. The aim of the Prep 10X concentrate and Cell Conditioning Solution CC1). ER present study was to investigate the potential effects of staining was performed using a Roche Ventana RTU Confirm anti- paclitaxel, carboplatin and 1,25-D3 on the growth of Estrogen Receptor Rabbit monoclonal antibody (Clone SP1) with endometrial cancer cells both as single agents and in 32 min incubation time. PR staining was performed using a Roche different combinations with each other in vitro . Ventana RTU Confirm anti-Progesterone Receptor Rabbit monoclonal antibody (Clone 1E2) with 24 min incubation time. Materials and Methods Both immunostainings were detected and visualized using Roche Ventana UltraView DAB IHC Detection Kit. Cell lines. Two endometrial adenocarcinoma cell lines were used Cell growth assays. For each experiment, the cells were plated on (UT-EC-1 and UT-EC-3) in this study. The cell lines were originally 24-well plates at 30,000 cells/well. Cells were then treated with established from primary tumors before any treatment using an indicated doses of paclitaxel (1-100 nM), carboplatin (0.1-20 μg/ml) explant technique (25, 26). UT-EC-1 was established from a and vitamin D (0.1-100 nM) alone or in combination. After a 3- curettage specimen of a clinical FIGO Stage II Grade 2 endometrial 3 day incubation period, the cells were trypsinized and counted using papillary adenocarcinoma and UT-EC-3 from the hysterectomy the Z2 Coulter Counter (Beckman Coulter, Fullerton, CA). All specimen of a surgical FIGO Stage Ia Grade 3 endometrial experiments were done in six replicates and were repeated at least adenocarcinoma (23). The biological properties of these cell lines twice. have been described in detail earlier (23). Statistical analyses. Non-parametrical Mann-Whitney test was used to Cell cultures and treatments. Prior to the experiments the cells were assess differences between treated and control groups. Exact p- values cultured as described previously (23). In brief, the cells were plated under 0.05 were considered as statistically significant. All statistical weekly and maintained in logarithmic phase in 75 cm 2 culture flasks analyses were performed using IBM SPSS Statistics version 23 (IBM in Dulbecco’s modified Eagle minimal essential medium (DMEM), SPSS Statistics, IBM Corporation, Chicago, IL). supplemented with 10% fetal bovine serum (FBS), 1% penicillin/streptomycin, 1% glutamine and 1% non-essential amino acids at 37ºC in a humidified atmosphere containing 5% CO 2. Both Results cell lines were tested negative for mycoplasma contamination. Paclitaxel (Hospira ® 6 mg/ml, Maidenhead, UK) and carboplatin The cells were first cultured with different concentrations of (Accord ® 10 mg/ml, Middlesex, UK) were provided by the Pharmacy of the Tampere University Hospital. 1,25-D3 was paclitaxel (1, 3, 5, 10, 50, and 100 nM) and carboplatin (0.1 purchased from Sigma-Aldrich (St.
Load more

Recommended publications
  • A Left/Right Comparison of Twice-Daily Calcipotriol Ointment and Calcitriol Ointment in Patients with Psoriasis: the Effect on Keratinocyte Subpopulations
    Acta Derm Venereol 2004; 84: 195–200 INVESTIGATIVE REPORT A Left/Right Comparison of Twice-Daily Calcipotriol Ointment and Calcitriol Ointment in Patients with Psoriasis: The Effect on Keratinocyte Subpopulations Mannon E.J. FRANSSEN, Gys J. DE JONGH, Piet E.J. VAN ERP and Peter C.M. VAN DE KERKHOF Department of Dermatology, University Medical Centre Nijmegen, The Netherlands Vitamin D3 analogues are a first-line treatment of Calcipotriol (Daivonex1,50mg/g ointment, Leo chronic plaque psoriasis, but so far, comparative clinical Pharmaceutical Products, Denmark) has been investi- studies on calcipotriol and calcitriol ointment are sparse, gated intensively during the last decade, and has proven and in particular no comparative studies are available on to be a valuable tool in the management of chronic cell biological effects of these compounds in vivo. Using plaque psoriasis. A review by Ashcroft et al. (1), based on flow cytometric assessment, we investigated whether these a large number of randomized controlled trials, showed compounds had different effects on the composition and that calcipotriol was at least as effective as potent DNA synthesis of epidermal cell populations responsible topical corticosteroids, 1a,-25-dihydroxycholecalciferol for the psoriatic phenotype. For 8 weeks, 20 patients with (calcitriol), short-contact dithranol, tacalcitol and coal psoriasis vulgaris were treated twice daily with calcipo- tar. Recently, Scott et al. (2) presented an overview of triol and calcitriol ointment in a left/right comparative studies on the use of calcipotriol ointment in the study. Before and after treatment, clinical assessment of management of psoriasis. They reconfirmed the super- target lesions was performed, together with flow cyto- ior efficacy of a twice-daily calcipotriol ointment metric analysis of epidermal subpopulations with respect regimen to the treatments as mentioned above, and to keratin (K) 10, K6, vimentin and DNA distribution.
    [Show full text]
  • Endocrine System WS19
    Endocrine System Human Physiology Unit 3 Endocrine System • Various glands located throughout the body • Some organs may also have endocrine functions • Endocrine glands/organs synthesize and release hormones • Hormones travel in plasma to target cells Functions of the Endocrine System • Differentiation of nervous and reproductive system during fetal development • Regulation of growth and development • Regulation of the reproductive system • Maintains homeostasis • Responds to changes from resting state Mechanisms of Hormone Regulation • Hormones have different rates and rhythms of secretion • Hormones are regulated by feedback systems to maintain homeostasis • Receptors for hormones are only on specific effector cells • Excretion of hormones vary for steroid hormones and peptide hormones Regulation of Hormone Secretion • Release of hormones occurs in response to • A change from resting conditions • Maintaining a regulated level of hormones or substances • Hormone release is regulated by • Chemical factors (glucose, calcium) • Endocrine factors (tropic hormones, HPA) HPA = Hypothalamic-Pituitary Axis • Neural controls (sympathetic activation) Hormone Feedback Systems Negative feedback maintains hormone concentrations within physiological ranges • Negative feedback • Feedback to one level Loss of • Long-loop Negative Feedback feedback • Feedback to two levels control often leads to • Hypothalamus-Pituitary-Gland Axis pathology Negative Feedback Short-Loop Negative Feedback Long-Loop Negative Feedback Hormone Transport Peptide/Protein Hormones
    [Show full text]
  • The Role of Reproductive Hormones in Epithelial Ovarian Carcinogenesis
    H Gharwan et al. Hormones and epithelial 22:6 R339–R363 Review ovarian cancer The role of reproductive hormones in epithelial ovarian carcinogenesis Helen Gharwan1, Kristen P Bunch2,3 and Christina M Annunziata2 1National Cancer Institute, National Institutes of Health, 10 Center Drive, Building 10, 12N226, Bethesda, Correspondence Maryland 20892-1906, USA should be addressed 2Women’s Malignancies Branch, National Cancer Institute, National Institutes of Health, Center for Cancer Research, to H Gharwan Bethesda, Maryland, USA Email 3Department of Gynecologic Oncology, Walter Reed National Military Medical Center, Bethesda, Maryland, USA [email protected] Abstract Epithelial ovarian cancer comprises w85% of all ovarian cancer cases. Despite acceptance Key Words regarding the influence of reproductive hormones on ovarian cancer risk and considerable " ovarian cancer advances in the understanding of epithelial ovarian carcinogenesis on a molecular level, " hormone action complete understanding of the biologic processes underlying malignant transformation of " reproductive ovarian surface epithelium is lacking. Various hypotheses have been proposed over the past " immune several decades to explain the etiology of the disease. The role of reproductive hormones in " endocrine epithelial ovarian carcinogenesis remains a key topic of research. Primary questions in the field of ovarian cancer biology center on its developmental cell of origin, the positive and negative effects of each class of hormones on ovarian cancer initiation and progression, and the role of the immune system in the ovarian cancer microenvironment. The development of the female reproductive tract is dictated by the hormonal milieu during embryogenesis. Endocrine-Related Cancer Intensive research efforts have revealed that ovarian cancer is a heterogenous disease that may develop from multiple extra-ovarian tissues, including both Mu¨ llerian (fallopian tubes, endometrium) and non-Mu¨ llerian structures (gastrointestinal tissue), contributing to its heterogeneity and distinct histologic subtypes.
    [Show full text]
  • A Clinical Update on Vitamin D Deficiency and Secondary
    References 1. Mehrotra R, Kermah D, Budoff M, et al. Hypovitaminosis D in chronic 17. Ennis JL, Worcester EM, Coe FL, Sprague SM. Current recommended 32. Thimachai P, Supasyndh O, Chaiprasert A, Satirapoj B. Efficacy of High 38. Kramer H, Berns JS, Choi MJ, et al. 25-Hydroxyvitamin D testing and kidney disease. Clin J Am Soc Nephrol. 2008;3:1144-1151. 25-hydroxyvitamin D targets for chronic kidney disease management vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin supplementation in CKD: an NKF-KDOQI controversies report. Am J may be too low. J Nephrol. 2016;29:63-70. D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD Kidney Dis. 2014;64:499-509. 2. Hollick MF. Vitamin D: importance in the prevention of cancers, type 1 with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial. diabetes, heart disease, and osteoporosis. Am J Clin Nutr 18. OPKO. OPKO diagnostics point-of-care system. Available at: http:// J Med Assoc Thai. 2015;98:643-648. 39. Jetter A, Egli A, Dawson-Hughes B, et al. Pharmacokinetics of oral 2004;79:362-371. www.opko.com/products/point-of-care-diagnostics/. Accessed vitamin D(3) and calcifediol. Bone. 2014;59:14-19. September 2 2015. 33. Kovesdy CP, Lu JL, Malakauskas SM, et al. Paricalcitol versus 3. Giovannucci E, Liu Y, Rimm EB, et al. Prospective study of predictors ergocalciferol for secondary hyperparathyroidism in CKD stages 3 and 40. Petkovich M, Melnick J, White J, et al. Modified-release oral calcifediol of vitamin D status and cancer incidence and mortality in men.
    [Show full text]
  • Endocrine Paraneoplastic Syndromes: a Review
    Endocrinology & Metabolism International Journal Review Article Open Access Endocrine paraneoplastic syndromes: a review Abstract Volume 1 Issue 1 - 2015 Paraneoplastic endocrine syndromes result from ectopic production of hormones by Hala Ahmadieh,1 Asma Arabi2 different tumors. Hypercalcemia of malignancy is the most common, mostly caused by 1Division of Endocrinology, American University of Beirut, ectopic parathyroid hormone related peptide (PTHrP) production which increases bone Lebanon resorption. Other causes include the rare ectopic parathyroid hormone (PTH) production, 2Department of Internal Medicine, American University of ectopic production of 1, 25-(OH)2 vitamin D by the tumor and its adjacent macrophages and Beirut-Medical Center, Lebanon bone metastasis which by itself in addition to the local production of PTHrP at the level of the bone lead to bone resorption and thus hypercalcemia. Treatment includes extracellular Correspondence: Asma Arabi, Department of Internal fluid volume repletion, bisphosphonates or denosumab and calcitonin. Ectopic Cushing’s Medicine, Division of Endocrinology, American University of syndrome caused by ectopic ACTH production results in hypokalemia, proximal muscle Beirut-Medical Center, Po Box 11-0236, Riad El-Solh, Beirut, weakness, easy bruisability, hypertension, diabetes and psychiatric abnormalities including Lebanon, Email depression and mood disorders. Different diagnostic measures help to differentiate Cushing’s disease from ectopic Cushing’s syndrome. Treatment includes surgical resection Received: October 26, 2014 | Published: January 02, 2015 of tumor and medical therapy to suppress excess cortisol production. Ectopic secretion of ADH has been associated with different tumor types. The best treatment options include removal of the underlying tumor, chemotherapy, or radiotherapy in addition to free water restriction, demeclocycline and vaptans.
    [Show full text]
  • TGF-Β Signaling Proteins and CYP24A1 May Serve As Surrogate
    1437 Original Article TGF-β signaling proteins and CYP24A1 may serve as surrogate markers for progesterone calcitriol treatment in ovarian and endometrial cancers of different histological types Ana Paucarmayta1, Hannah Taitz1, Yovanni Casablanca1,2,3, Gustavo C. Rodriguez4, G. Larry Maxwell2,3,5, Kathleen M. Darcy2,3,6, Viqar Syed1,3,7 1Department of Obstetrics and Gynecology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA; 2Gynecologic Cancer Center of Excellence, 3John P. Murtha Cancer Center, Department of Obstetrics and Gynecology, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, MD, USA; 4Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL, USA; 5Department of Obstetrics and Gynecology, Inova Fairfax Hospital, Falls Church, VA, USA; 6Inova Schar Cancer Institute, Inova Center for Personalized Health, Falls Church, VA, USA; 7Department of Molecular and Cell Biology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA Contributions: (I) Conception and design: KM Darcy, GL Maxwell, V Syed; (II) Administrative support: None; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: A Paucarmayta, H Taitz, V Syed; (V) Data analysis and interpretation: A Paucarmayta, H Taitz, KM Darcy, V Syed; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Viqar Syed. John P. Murtha Cancer Center, Department of Obstetrics and Gynecology, Department of Molecular and Cell Biology, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Room# A-3080, Bethesda, MD, USA. Email: [email protected]. Background: Strategies are needed to coordinately block drivers and induce suppressors of cancer to reduce incidence and improve outcomes for individuals with inherited or acquired risk.
    [Show full text]
  • Vitamin D3 Constrains Estrogen's Effects and Influences Mammary
    www.nature.com/scientificreports OPEN Vitamin D3 constrains estrogen’s efects and infuences mammary epithelial organization in 3D Received: 16 January 2019 Accepted: 18 April 2019 cultures Published: xx xx xxxx Nafs Hasan 1, Carlos Sonnenschein1,2 & Ana M. Soto 1,2 Vitamin D3 (vitD3) and its active metabolite, calcitriol (1,25-(OH)2D3), afect multiple tissue types by interacting with the vitamin D receptor (VDR). Although vitD3 defciency has been correlated with increased incidence of breast cancer and less favorable outcomes, randomized clinical trials have yet to provide conclusive evidence on the efcacy of vitD3 in preventing or treating breast cancer. Additionally, experimental studies are needed to assess the biological plausibility of these outcomes. The mammary gland of VDR KO mice shows a forid phenotype revealing alterations of developmental processes that are largely regulated by mammotropic hormones. However, most research conducted on vitD3’s efects used 2D cell cultures and supra-physiological doses of vitD3, conditions that spare the microenvironment in which morphogenesis takes place. We investigated the role of vitD3 in mammary epithelial morphogenesis using two 3D culture models. VitD3 interfered with estrogen’s actions on T47D human breast cancer cells in 3D diferently at diferent doses, and recapitulated what is observed in vivo. Also, vitD3 can act autonomously and afected the organization of estrogen-insensitive MCF10A cells in 3D collagen matrix by infuencing collagen fber organization. Thus, vitD3 modulates mammary tissue organization independent of its efects on cell proliferation. Breast cancer remains a major cause of mortality among women worldwide. Epidemiological studies have shown that key stages during breast development are particularly susceptible to the efects of carcinogens.
    [Show full text]
  • Calcitriol, Parathyroid Hormone, and Accumulation of Aluminum in Bone in Dogs with Renal Failure
    Calcitriol, parathyroid hormone, and accumulation of aluminum in bone in dogs with renal failure. H H Malluche, … , C Matthews, P Fanti J Clin Invest. 1987;79(3):754-761. https://doi.org/10.1172/JCI112881. Research Article Accumulation of aluminum in bone is a frequent finding in patients requiring chronic dialysis and is associated with considerable morbidity and/or mortality. Until now, evidence seemed to point to relatively low circulating levels of parathyroid hormone as a contributing factor, but because levels of parathyroid hormone and calcitriol are interrelated, calcitriol might be also involved. In this study we employed an animal model to evaluate the single and combined effects of parathyroid hormone and calcitriol on bone aluminum accumulation. The results show significantly less aluminum accumulation in calcitriol-replete dogs independent of the presence or absence of parathyroid hormone. These results indicate that low levels of calcitriol may play a role in the development of aluminum related bone disease. Further studies are needed to demonstrate whether administration of calcitriol in patients with renal insufficiency will prevent development of aluminum-related bone disease. Find the latest version: https://jci.me/112881/pdf Calcitriol, Parathyroid Hormone, and Accumulation of Aluminum in Bone in Dogs with Renal Failure Hartmut H. Malluche, Marie-Claude Faugere, Robert M. Friedler, Clifford Matthews, and Paolo Fanti Division ofNephrology, Bone and Mineral Metabolism, Department ofMedicine, University ofKentucky, Lexington, Kentucky 40536-0084 Abstract We found patients with predominant hyperparathyroid bone disease to have less stainable bone aluminum than those with Accumulation of aluminum in bone is a frequent finding in pa- mixed uremic osteodystrophy or low turnover osteomalacia (8) tients requiring chronic dialysis and is associated with consid- whereas Alfrey et al.
    [Show full text]
  • The Interfaces Between Vitamin D, Sleep and Pain
    234 1 D L DE OLIVEIRA and others Sleep and pain: the role of 234:1 R23–R36 Review vitamin D The interfaces between vitamin D, sleep and pain Correspondence Daniela Leite de Oliveira, Camila Hirotsu, Sergio Tufik and Monica Levy Andersen should be addressed to C Hirotsu Department of Psychobiology, Universidade Federal de São Paulo, São Paulo, Brazil Email [email protected] Abstract The role of vitamin D in osteomineral metabolism is well known. Several studies have Key Words suggested its action on different biological mechanisms, such as nociceptive sensitivity f sleep and sleep–wake cycle modulation. Sleep is an important biological process regulated f vitamin D by different regions of the central nervous system, mainly the hypothalamus, in f pain combination with several neurotransmitters. Pain, which can be classified as nociceptive, f hyperalgesia neuropathic and psychological, is regulated by both the central and peripheral nervous systems. In the peripheral nervous system, the immune system participates in the inflammatory process that contributes to hyperalgesia. Sleep deprivation is an important condition related to hyperalgesia, and recently it has also been associated with vitamin D. Poor sleep efficiency and sleep disorders have been shown to have an important role Endocrinology in hyperalgesia, and be associated with different vitamin D values. Vitamin D has been of inversely correlated with painful manifestations, such as fibromyalgia and rheumatic diseases. Studies have demonstrated a possible action of vitamin D in the regulatory Journal mechanisms of both sleep and pain. The supplementation of vitamin D associated with good sleep hygiene may have a therapeutic role, not only in sleep disorders but also in Journal of Endocrinology the prevention and treatment of chronic pain conditions.
    [Show full text]
  • Anti-Proliferative and Apoptotic Activities of Müllerian Inhibiting Substance Combined with Calcitriol in Ovarian Cancer Cell Lines
    Original Article Yonsei Med J 2016 Jan;57(1):33-40 http://dx.doi.org/10.3349/ymj.2016.57.1.33 pISSN: 0513-5796 · eISSN: 1976-2437 Anti-Proliferative and Apoptotic Activities of Müllerian Inhibiting Substance Combined with Calcitriol in Ovarian Cancer Cell Lines Yeon Soo Jung1,2, Hee Jung Kim2, Seok Kyo Seo2,3, Young Sik Choi2,3, Eun Ji Nam2,3, Sunghoon Kim2,3, Sang Wun Kim2,3, Hyuck Dong Han1, Jae Wook Kim2,3, and Young Tae Kim2,3 1Department of Obstetrics and Gynecology, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju; 2Institute of Women’s Life Medical Science, Yonsei University College of Medicine, Seoul; 3Department of Obstetrics and Gynecology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. Purpose: This study aimed to investigate whether Müllerian inhibiting substance (MIS) in combination with calcitriol modulates proliferation and apoptosis of human ovarian cancer (OCa) cell lines (SKOV3, OVCAR3, and OVCA433) and identify the signaling pathway by which MIS mediates apoptosis. Materials and Methods: OCa cell lines were treated with MIS in the absence or presence of calcitriol. Cell viability and prolifera- tion were evaluated using the Cell Counting Kit-8 assay and apoptosis was evaluated by DNA fragmentation assay. Western blot and enzyme-linked immunosorbent assay were used to determine the signaling pathway. Results: The cells showed specific staining for the MIS type II receptor. Treatment of OCa cells with MIS and calcitriol led to dose- and time-dependent inhibition of cell growth and survival. The combination treatment significantly suppressed cell growth, down- regulated the expression of B-cell lymphoma 2 (Bcl-2), and up-regulated the expressions of Bcl-2 associated X protein, caspase-3, and caspase-9 through the extracellular signal-regulated kinase signaling pathway.
    [Show full text]
  • Hypoparathyroidism and Digeorge Syndrome
    Endocrinology and Diabetes Clinic Disorders of Calcium 4480 Oak Street, Vancouver, BC V6H 3V4 604-875-2117 1-888-300-3088 x2117 and Phosphorus http://endodiab.bcchildrens.ca Hypoparathyroidism the parathyroid cells. The body has developed cells that destroy some of its Hypoparathyroidism occurs when the body own tissue. This may include other does not produce enough parathyroid organs and endocrine glands, causing hormone (PTH). This hormone is made in 4 type 1 diabetes, Addison disease or or 5 parathyroid glands, located behind the other autoimmune diseases. thyroid tissue in the neck area. They are 2. Surgery or radiation to the thyroid gland very small—the size of peas. Their only job which damages the parathyroid glands. is to produce PTH, which keeps the calcium levels in the blood in the right range. 3. Iron deposits in the parathyroid glands, a side-effect of repeated transfusions to The name “hypo-parathyroid-ism”, means a treat thalassemia or other blood condition of low parathyroid hormone. diseases What does PTH do? How is hypoparathyroidism diagnosed? PTH balances the calcium level in the blood, keeping it in the right range. When the Something will have happened to make your calcium level is low, PTH is produced and it doctor request special blood tests. Perhaps raises the calcium level by: a heart problem is discovered during a routine pregnancy ultrasound or at birth, or 1. Moving calcium from the bones into the perhaps your baby or child became very sick blood. with symptoms of low blood calcium (see 2. Decreasing how much calcium is handout Disorders of Calcium and eliminated from the blood into the urine Phosphorus).
    [Show full text]
  • Hypoparathyroidism • Always Carry Spare Medication with You
    Taking Tablets Living with hypoparathyroidism • Always carry spare medication with you. Many people with Hypopara can expect to lead Hypoparathyroidism • Try to maintain a month’s supply in reserve. normal lives with a normal life span. • Carry an extra supply of medication on holiday. • With permanent but mild Hypopara, temporary • Carry your medication in your hand luggage symptoms may occur from time to time. when travelling by plane, with prescription • Severe Hypopara is rare but you may experience labels visible. constantly unstable calcium levels (or brittle Hypopara) and a range of symptoms which can Does anything affect my calcium level? be very challenging. You should be referred to a • Diet: It is better to get your calcium from your specialist in calcium metabolism. food than from supplements. However, some • You may experience episodes of unusual fatigue foods, e.g. too much wholemeal bread, spinach Further information and support are available or muscle weakness. At times you will need to from Hypopara UK, a national voluntary patient or tomatoes, alcohol and fizzy drinks can deplete allow your body to catch up, with extra rest. calcium. Dehydration also affects calcium levels: organisation, working to support people with all • Women with Hypopara can have a healthy drink eight glasses of water daily. forms of hypoparathyroidism and to promote pregnancy and a normal childbirth. Calcium, better medical understanding of this rare • Calcium levels can be affected by: vitamin D and thyroid hormone doses may need parathyroid condition. illness, infection, fever, sweating, vomiting, adjusting throughout pregnancy. diarrhoea,dehydration, surgery (including Free Membership|Support Groups|Information • You may need extra medication during strenuous dental), stress, smoking, menstrual periods, physical exercise.
    [Show full text]